Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metreleptin and Pramlintide in Obese and Overweight Subjects
NCT00673387Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Primary completion
- Apr 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of metreleptin, pramlintide in obesity, sponsored by AstraZeneca. Started Apr 2008; status: completed.
02
Drugs
metreleptinpramlintide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00673387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673387.